Suggest Avoiding Savaysa for A Fib if CrCl is OVER 95 mL/min

March 2015

Savaysa (sa-VAYE-sah, edoxaban) will be the fourth new oral anticoagulant...after Pradaxa, Xarelto, and Eliquis.

It's approved for atrial fib and venous thromboembolism (VTE).

But Savaysa has an odd twist when used for A fib. It does NOT work as well as warfarin in patients with NORMAL kidney function.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote